NYSE:CAH - Cardinal Health Stock Price, Forecast & News

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Thursday, November 7th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.481 per share on Wednesday, January 15th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 3.57%. The ex-dividend date of this dividend is Tuesday, December 31st. View Cardinal Health's Dividend History.

Cardinal Health announced that its board has approved a share buyback program on Thursday, November 8th 2018, which allows the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) posted its quarterly earnings data on Thursday, November, 7th. The company reported $1.27 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.09 by $0.18. The company earned $37.34 billion during the quarter, compared to the consensus estimate of $36.75 billion. Cardinal Health had a negative net margin of 2.81% and a positive return on equity of 32.25%. The firm's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.29 EPS. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Cardinal Health.

Cardinal Health will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cardinal Health issued an update on its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $4.85-5.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.99.

6 brokers have issued 1-year target prices for Cardinal Health's shares. Their forecasts range from $41.00 to $55.00. On average, they expect Cardinal Health's stock price to reach $50.00 in the next year. This suggests that the stock has a possible downside of 7.3%. View Analyst Price Targets for Cardinal Health.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

News stories about CAH stock have been trending somewhat positive this week, InfoTrie reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cardinal Health earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Exxon Mobil (XOM), CVS Health (CVS), Becton Dickinson and (BDX), Verizon Communications (VZ), Pfizer (PFE), Gilead Sciences (GILD) and PepsiCo (PEP).

Cardinal Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Commerzbank Aktiengesellschaft FI (0.05%), Kempner Capital Management Inc. (0.04%), Nisa Investment Advisors LLC (0.04%), Kwmg LLC (0.03%), Inlet Private Wealth LLC (0.03%) and Advisors Capital Management LLC (0.02%). Company insiders that own Cardinal Health stock include Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Zeke Capital Advisors LLC, United Services Automobile Association, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Advisors Capital Management LLC, Livingston Group Asset Management CO operating as Southport Capital Management, Welch & Forbes LLC and Sawyer & Company Inc. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Sage Capital Advisors llc, Meag Munich Ergo Kapitalanlagegesellschaft MBH, DNB Asset Management AS, CLARET ASSET MANAGEMENT Corp, Alpine Global Management LLC, Inlet Private Wealth LLC and LFA Lugano Financial Advisors SA. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $53.93.

Cardinal Health has a market capitalization of $15.77 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe.View Additional Information About Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]